Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Cordis helps test GenVec's BioBypass

Executive Summary

GenVec (gene therapy) will partner with the cardiology division of J&J's Cordis Corp. to measure the clinical benefit of delivering GenVec's drug candidate BioBypass directly into heart tissue using Cordis's Nogastar mapping catheter and Myostar injection catheter.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Chiral Chemistry
    • Drug Delivery
      • Site Specific
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies